人民同泰公告，控股股东哈药集团股份有限公司持有4.34亿股，占74.82%，计划自2025年12月11日至 2026年3月10日，通过集中竞价方式减持公司股份不超过579.88万股，占公司总股本不超过1%。 ...

哈药股份公告，公司持有人民同泰4.34亿股，占74.82%，拟通过集中竞价减持不超过579.88万股，占人 民同泰总股本不超过1%。减持期限为人民同泰公告披露后十五个交易日后的三个月内，减持价格将依 据市场价确定。2025年11月19日，公司董事会已审议通过相关议案，本次事项无需提交股东会审议，亦 不构成关联交易和重大资产重组。 ...

南财智讯11月19日电，人民同泰公告，公司控股股东哈药集团股份有限公司持有公司股份433,894,354 股，占公司总股本的74.82%。哈药股份根据经营需要，计划自公告披露之日起15个交易日后的3个月 内，通过集中竞价交易方式减持公司股份不超过580万股，占公司总股本的比例不超过1%。本次减持计 划不会导致公司控制权发生变更，实际减持数量和价格存在不确定性。 ...

人民同泰11月19日交易公开信息 人民同泰(600829)今日跌停，全天换手率11.23%，成交额10.60亿元，振幅9.59%。龙虎榜数据显示，营 业部席位合计净卖出1224.86万元。 上交所公开信息显示，当日该股因日跌幅偏离值达-10.16%上榜，营业部席位合计净卖出1224.86万元。 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交1.98亿元，其中，买入成交额为9282.99 万元，卖出成交额为1.05亿元，合计净卖出1224.86万元。 具体来看，今日上榜营业部中，第一大买入营业部为国信证券股份有限公司浙江互联网分公司，买入金 额为3071.06万元，第一大卖出营业部为华泰证券股份有限公司厦门厦禾路证券营业部，卖出金额为 2342.67万元。 近半年该股累计上榜龙虎榜10次，上榜次日股价平均涨1.25%，上榜后5日平均涨7.62%。 资金流向方面，今日该股主力资金净流出8192.09万元，其中，特大单净流出4034.18万元，大单资金净 流出4157.91万元。近5日主力资金净流出7.22亿元。 10月21日公司发布的三季报数据显示，前三季度公司共实现营业收入78.46亿元，同比增长2. ...

Market Overview - The pharmaceutical commercial sector declined by 1.33% on November 19, with Renmin Tongtai leading the losses [1] - The Shanghai Composite Index closed at 3946.74, up 0.18%, while the Shenzhen Component Index closed at 13080.09, unchanged [1] Stock Performance - Key stocks in the pharmaceutical commercial sector showed varied performance, with Jianfa Zhixin rising by 3.19% to a closing price of 34.00, while Renmin Tongtai fell by 9.99% to 15.95 [2][1] - The trading volume for Jianfa Zhixin was 180,800 shares, with a transaction value of 620 million yuan [1] - Other notable stocks included Yifeng Pharmacy, which increased by 0.46%, and Shanghai Pharmaceuticals, which decreased by 0.39% [1] Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 436 million yuan from institutional investors, while retail investors saw a net inflow of 408 million yuan [2] - The data indicates that retail investors are more active in the sector despite the overall decline in stock prices [2] Individual Stock Capital Flow - Jianfa Zhixin had a net inflow of 70.39 million yuan from institutional investors, while Renmin Tongtai saw a significant outflow of 1.20 billion yuan from retail investors [3] - Other stocks like Guoyao Yizhi and Zhongyao Holdings also experienced mixed capital flows, with Guoyao Yizhi having a net inflow of 7.36 million yuan from institutional investors [3]

（文章来源：每日经济新闻） 每经AI快讯，11月19日，医药商业板块持续走低，人民同泰触及跌停，漱玉平民、鹭燕医药、华人健 康跟跌。 ...

医药商业板块持续走低，人民同泰跌停，漱玉平民、鹭燕医药、华人健康跟跌。 ...

Core Viewpoint - The stock of Renmin Tongtai (600829) experienced a significant increase of 6.49% today, with a trading volume of 1.902 billion yuan and a fluctuation of 21.03% [2][3]. Trading Activity - The stock was listed on the Shanghai Stock Exchange's "Dragon and Tiger List" due to its daily fluctuation reaching 21.03%, with a net buying amount of 23.9629 million yuan from brokerage seats [2]. - The top five brokerage seats accounted for a total trading volume of 250 million yuan, with a buying amount of 137 million yuan and a selling amount of 113 million yuan, resulting in a net buying of 23.9629 million yuan [2][3]. - The largest buying brokerage was Guosen Securities Co., Ltd. Zhejiang Internet Branch, with a buying amount of 40.8909 million yuan, while the largest selling brokerage was Guosheng Securities Co., Ltd. Ningbo Sangtian Road Securities Brokerage, with a selling amount of 30.2542 million yuan [2][3]. Recent Performance - Over the past six months, the stock has appeared on the Dragon and Tiger List nine times, with an average price increase of 2.65% the day after being listed and an average increase of 12.76% over the following five days [3]. - However, today the stock saw a net outflow of 165 million yuan in main funds, with large orders contributing to a net outflow of 65.7221 million yuan and 99.0066 million yuan respectively. In the past five days, the total net outflow of main funds reached 618 million yuan [3]. Financial Results - The company reported its third-quarter results on October 21, showing a total revenue of 7.846 billion yuan for the first three quarters, representing a year-on-year growth of 2.19%. However, net profit decreased by 45.69% to 112 million yuan [3].

Investment Rating - The report does not provide a specific investment rating for the industry or companies mentioned [1]. Core Insights - The report highlights several new stock listings and trading activities scheduled for November 18, 2025, including companies such as Jingchuang Electric (12.10), Beikang Testing (6.70), and Nanguang Digital (5.69) [1]. - It also mentions various corporate actions such as tender offers, cash options, and acquisition requests, indicating active market movements [1]. Summary by Relevant Sections - **New Stock Listings**: Companies like Jingchuang Electric, Beikang Testing, and Nanguang Digital are set to debut on the market with respective prices of 12.10, 6.70, and 5.69 [1]. - **Corporate Actions**: The report details several corporate actions including a tender offer for Tianpu Co. (605255) from November 20 to December 19, 2025, and cash options for Hangqi Wheel B (200771) from November 19 to November 25, 2025 [1]. - **Market Alerts**: It lists companies experiencing significant fluctuations, such as Moen Electric (002451) and Huasheng Lithium Battery (688353), indicating potential investment risks and opportunities [1].

Market Overview - The pharmaceutical commercial sector experienced a decline of 0.92% on November 18, with Yao Yigou leading the drop [1] - The Shanghai Composite Index closed at 3939.81, down 0.81%, while the Shenzhen Component Index closed at 13080.49, down 0.92% [1] Stock Performance - Notable gainers included: - Ren Da Medical (603108) with a closing price of 15.97, up 2.90% and a trading volume of 278,200 shares, totaling 442 million yuan [1] - People's Tongtai (600829) with a closing price of 17.72, up 6.49% and a trading volume of 1,148,700 shares, totaling 1.902 billion yuan [1] - Major decliners included: - Yao Yigou (300937) with a closing price of 33.95, down 6.37% and a trading volume of 115,000 shares, totaling 396 million yuan [2] - Luhua Pharmaceutical (002788) with a closing price of 10.29, down 5.86% and a trading volume of 467,300 shares, totaling 489 million yuan [2] Capital Flow - The pharmaceutical commercial sector saw a net outflow of 706 million yuan from institutional investors, while retail investors contributed a net inflow of 705 million yuan [2] - The overall capital flow indicates a mixed sentiment, with institutional investors withdrawing while retail investors remained active [2] Individual Stock Capital Flow - Ren Da Medical (603108) had a net inflow of 49.2 million yuan from institutional investors, while retail investors saw a net outflow of 65.5 million yuan [3] - Yao Yigou (300937) experienced a significant net outflow of 560.4 million yuan from institutional investors [3] - The data reflects varying levels of investor confidence across different stocks within the sector [3]